Correlation of Serum and Urine Sialic Acid Levels with Lipid Profile and Anthropometric Indices in Type 2 Diabetes Mellitus and Diabetic Nephropathy

Prajna, K.; Rai, Srinidhi; Rai, Tirthal

doi:10.9734/ijbcrr/2018/43386

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a study of Prajna K. et al type II diabetes patients with and without nephropathy were compared and it was claimed that such microvascular complications as diabetic nephropathy were more frequently observed in patients with high total sialic acid level, and as a potential risk factor in the development of nephropathy. In another study, a high level of serum total SA was postulated to be a potential prognostic indicator of diabetic nephropathy (14,15).…”

Section: Discussionmentioning

confidence: 98%

Evaluation of Sialic Acid Levels in the Umbilical Cord Blood of Newborns of Diabetic and Non-Diabetic Mothers and the Relation with Poor Neonatal Outcome

Uyar

Murat

Alan

2020

Gynecol Obstet Reprod Med

View full text Add to dashboard Cite

Objective: The aim of this study is to evaluate sialic acid levels in cord blood samples of infants of natal diabetic and non-diabetic pregnancies and to assess the correlation of sialic acid levels with the poor neonatal outcomes.Study Design: The study was conducted between January 2016 and February 2018 with 48 diabetic patients and 39 non-diabetic patients. The inclusion criteria were participants should have an oral glucose tolerance test, patients should not have rheumatic or metabolic diseases, and the follow-up visits during whole pregnancy should be in our hospital. Sialic acid levels of the participants were assessed from the newborn cord blood within the first 6-24 hours postnatally. Also mean platelet volume, mean corpuscular hemoglobin concentration, mean corpuscular hemoglobin, platelet, bilirubin values were recorded as well as the age, gravida, parity, gestational week of the participant mothers and type of delivery, gender, weight, height and the APGAR score of the newborn, and whether insulin was used or not. SPSS statistical program was used to interpret the obtained data.Results: A total of 87 patients were included in the study, 48 from the diabetic patient group and 39 from the control group. There was no difference in sialic acid levels between the two groups (p=0.155). When the diabetic group was divided into subgroups, the group with the highest sialic acid level was type I diabetes (46.25±3.6). The others, in decreasing order, were participants with Type II diabetes (33.00±4.1) and gestational diabetes (20.87±3.7) and the difference was statistically significant (p=0.001). Those who were diabetic and on insulin treatment had significantly higher sialic acid values than those who were on diabetic diet only (p=0.007). When the sialic acid is compared in participants with higher blood glucose levels with those with a lower blood glucose level sialic acid concentration was lower in those with higher blood glucose. (p=0.006). Between these two groups, no difference was found regarding the poor neonatal outcomes and laboratory parameters (p >0.05).Conclusion: Infants of diabetic and non-diabetic patients in pregnancy had no difference in sialic acid blood levels and neonatal outcomes in cord blood. However, among diabetic groups, sialic acid levels were higher in type I diabetic group than in other diabetic groups

show abstract

Section: Discussionmentioning

confidence: 98%